MindMed Archives

Psychedelics News

MindMed

Industry

17 Dec 2021

MindMed Initiates Phase 2a LSD Trial

MindMed begins its Phase 2a trial using LSD to treat ADHD...

By Microdose

Breaking News, Industry

15 Nov 2021

MindMed Announces Financial Results and Business Highlights

Quarterly updates are important tools to not only stay updated on a company’s progress but to remind us that an absence of headlines doesn’t mean a lack of progress....

By Jason Najum

Industry

27 Oct 2021

MindMed Expands its Pipeline with Launch of MDMA Program

MindMed already has one of the industry’s top development programs....

By Jason Najum

Don’t Miss

18 Oct 2021

News You Might Have Missed: Oct 18

Welcome to the News You Might Have Missed, a weekly roundup of news items to help you catch up and stay informed....

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

17 Feb 2021

MindMed’s LSD Neutralizer Study Begins

Potential Emergency Off-Switch for Psychedelic Assisted Therapies BASEL, SwitzerlandFeb....

By Microdose

Press Releases

11 Feb 2021

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

SwitzerlandFeb....

By Microdose

Press Releases

20 Jan 2021

MindMed Announces the Start of the First-Ever Clinical Trial Combining MDMA and LSD

BASEL, SwitzerlandJan....

By Microdose

Press Releases

14 Jan 2021

MindMed Adds Chief Development Officer with FDA Phase 2 Psilocybin Clinical Trial Experience

Psychedelic Pharmaceutical Scientist and Clinical Pharmacologist Robert Barrow Appointed as Chief Development Officer NEW YORKJan....

By Microdose

Press Releases

12 Jan 2021

MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers

MindMed to Commence Groundbreaking LSD Microdosing Study Evaluating Benefits on Neuroplasticity, Sleep, Cognitive Enhancement Variables and Immune System Response on the Human Body NEW YORKJan....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result